Keywords: lilly, emr, india, violative, trips, eli, may

Lilly EMR in India violative of TRIPs?

Article | 25 July 2000

Print This

Eli Lilly may have been convinced that its plan to seek exclusivemarketing rights in India for its antipsychotic Zyprexa (olanzapine) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in